Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Frank Scott

Concepts (325)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inflammatory Bowel Diseases
28
2026
349
8.670
Why?
Crohn Disease
16
2025
249
5.640
Why?
Gastrointestinal Agents
7
2025
65
3.440
Why?
Gastroenterology
7
2025
178
2.180
Why?
Colitis, Ulcerative
9
2025
136
2.130
Why?
Infliximab
10
2022
111
1.570
Why?
Intestinal Obstruction
3
2021
51
1.500
Why?
Tissue Adhesions
3
2021
32
1.270
Why?
Immunosuppressive Agents
6
2020
863
1.270
Why?
Adrenal Cortex Hormones
4
2022
491
1.140
Why?
Antibodies, Monoclonal, Humanized
5
2025
821
1.130
Why?
Tumor Necrosis Factor-alpha
10
2023
1243
1.120
Why?
Algorithms
7
2026
1701
1.040
Why?
Patient Acceptance of Health Care
5
2026
849
0.980
Why?
Intestine, Small
2
2021
155
0.980
Why?
Biological Products
4
2026
222
0.950
Why?
Ustekinumab
2
2025
16
0.910
Why?
JC Virus
2
2015
23
0.890
Why?
Leukoencephalopathy, Progressive Multifocal
2
2015
37
0.870
Why?
Drug Monitoring
1
2026
209
0.870
Why?
Azathioprine
5
2021
49
0.820
Why?
Humans
91
2026
137601
0.810
Why?
Bone Diseases, Metabolic
1
2023
64
0.800
Why?
Abdomen
2
2021
128
0.770
Why?
Esophageal Neoplasms
6
2022
319
0.760
Why?
Abdominal Abscess
1
2022
25
0.760
Why?
Postoperative Complications
3
2021
2665
0.710
Why?
Gastrointestinal Hemorrhage
3
2023
134
0.700
Why?
Retrospective Studies
27
2026
15720
0.690
Why?
Severity of Illness Index
9
2025
2840
0.680
Why?
Anti-Bacterial Agents
5
2018
1799
0.680
Why?
Splints
1
2020
14
0.670
Why?
Capsule Endoscopy
1
2020
18
0.660
Why?
Antibodies, Viral
2
2015
648
0.660
Why?
Biosimilar Pharmaceuticals
1
2020
24
0.650
Why?
Barrett Esophagus
4
2023
150
0.640
Why?
Radius Fractures
1
2020
60
0.630
Why?
Biomedical Research
2
2019
696
0.620
Why?
Quality-Adjusted Life Years
5
2021
108
0.600
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2021
448
0.590
Why?
Spondylarthritis
3
2025
50
0.590
Why?
Colonoscopy
7
2024
249
0.590
Why?
Adult
37
2026
37910
0.580
Why?
Hospitalization
4
2026
2197
0.580
Why?
Drug Utilization
1
2019
168
0.570
Why?
Intestinal Fistula
1
2018
18
0.570
Why?
Colonic Diseases
1
2018
34
0.560
Why?
Surgical Procedures, Operative
1
2021
260
0.560
Why?
Health Resources
1
2019
124
0.560
Why?
Pericardium
1
2018
55
0.560
Why?
Tuberculin Test
1
2017
36
0.560
Why?
Cost-Benefit Analysis
5
2021
592
0.550
Why?
Biological Factors
2
2023
39
0.540
Why?
Epstein-Barr Virus Infections
1
2018
98
0.530
Why?
Models, Statistical
2
2019
666
0.530
Why?
Male
48
2026
67690
0.530
Why?
Middle Aged
37
2026
33441
0.520
Why?
Latent Tuberculosis
1
2017
68
0.520
Why?
Time-to-Treatment
2
2019
204
0.520
Why?
Mass Screening
4
2021
1279
0.520
Why?
Colorectal Neoplasms
6
2024
801
0.500
Why?
Treatment Outcome
14
2025
10813
0.490
Why?
Remission Induction
3
2025
290
0.490
Why?
Antibodies, Monoclonal
4
2021
1425
0.480
Why?
Natalizumab
1
2015
40
0.460
Why?
Radius
1
2015
50
0.460
Why?
Heart Diseases
1
2018
328
0.450
Why?
Fracture Fixation
1
2015
79
0.440
Why?
Mycobacterium tuberculosis
1
2017
317
0.440
Why?
Female
44
2026
73359
0.430
Why?
Age Factors
5
2025
3253
0.430
Why?
Models, Theoretical
1
2018
578
0.430
Why?
Practice Patterns, Physicians'
3
2024
1299
0.420
Why?
Aged
27
2024
23938
0.410
Why?
Leukocyte L1 Antigen Complex
2
2026
31
0.410
Why?
Markov Chains
3
2020
125
0.400
Why?
Lymphoma
1
2014
210
0.390
Why?
Risk Factors
17
2025
10319
0.390
Why?
Drug Therapy, Combination
4
2024
1036
0.380
Why?
Adalimumab
3
2021
53
0.370
Why?
Communicable Diseases
1
2014
161
0.370
Why?
Patient Discharge
2
2023
901
0.360
Why?
Feces
3
2026
480
0.360
Why?
United Kingdom
5
2021
317
0.360
Why?
Gastroenterologists
2
2022
18
0.350
Why?
Professional Competence
1
2012
97
0.350
Why?
Disease Management
3
2021
619
0.350
Why?
Cohort Studies
10
2025
5691
0.340
Why?
Carcinoma, Squamous Cell
1
2016
645
0.330
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2013
353
0.330
Why?
Spondylitis, Ankylosing
2
2021
47
0.330
Why?
Research Design
2
2019
1110
0.330
Why?
Fractures, Bone
1
2015
393
0.330
Why?
Gastroesophageal Reflux
2
2023
239
0.320
Why?
Research Personnel
1
2012
184
0.320
Why?
Colonic Polyps
2
2024
88
0.320
Why?
Adenoma
3
2024
225
0.320
Why?
United States
17
2025
14925
0.310
Why?
Proportional Hazards Models
5
2021
1272
0.310
Why?
Urinary Bladder Neoplasms
3
2017
261
0.300
Why?
Pediatric Obesity
1
2016
591
0.300
Why?
Societies, Medical
4
2025
818
0.290
Why?
Janus Kinase Inhibitors
2
2025
27
0.290
Why?
Skin Neoplasms
1
2016
849
0.290
Why?
Randomized Controlled Trials as Topic
3
2025
1468
0.280
Why?
Quality of Life
2
2021
2942
0.280
Why?
Electronic Health Records
6
2022
1073
0.280
Why?
Incidence
8
2021
2805
0.280
Why?
Databases, Factual
7
2018
1382
0.260
Why?
Mortality
2
2020
354
0.260
Why?
Neoplasm Recurrence, Local
3
2017
1038
0.250
Why?
Maintenance Chemotherapy
1
2025
36
0.240
Why?
Radiography
2
2020
844
0.240
Why?
Referral and Consultation
2
2023
794
0.240
Why?
Consensus
2
2025
673
0.240
Why?
Population Surveillance
2
2021
479
0.230
Why?
Induction Chemotherapy
1
2025
77
0.230
Why?
Antifungal Agents
2
2016
140
0.230
Why?
Aged, 80 and over
10
2020
7609
0.230
Why?
Case-Control Studies
8
2021
3550
0.220
Why?
Evidence-Based Medicine
2
2025
739
0.220
Why?
Recurrence
5
2021
1073
0.220
Why?
Esophageal Stenosis
2
2014
55
0.210
Why?
Delivery of Health Care
2
2021
952
0.210
Why?
Surveys and Questionnaires
8
2025
5835
0.210
Why?
Adenocarcinoma
2
2021
881
0.210
Why?
Gastrointestinal Microbiome
2
2022
699
0.210
Why?
Obesity
1
2017
2985
0.210
Why?
Diagnosis, Computer-Assisted
1
2024
90
0.200
Why?
C-Reactive Protein
1
2026
411
0.200
Why?
Colectomy
2
2021
100
0.200
Why?
Esophagitis, Peptic
1
2023
15
0.200
Why?
Protective Factors
2
2021
95
0.200
Why?
Models, Economic
2
2020
59
0.200
Why?
Glucocorticoids
2
2018
528
0.200
Why?
Logistic Models
6
2018
2076
0.200
Why?
Absorptiometry, Photon
1
2023
262
0.200
Why?
Prognosis
4
2019
3966
0.190
Why?
Comparative Effectiveness Research
2
2024
153
0.190
Why?
Cellulitis
1
2022
55
0.190
Why?
Medical Marijuana
1
2024
121
0.190
Why?
Odds Ratio
4
2018
1074
0.180
Why?
Insurance, Health
1
2024
288
0.180
Why?
Amputation, Traumatic
1
2021
20
0.180
Why?
Necrosis
1
2022
247
0.180
Why?
Finger Injuries
1
2021
25
0.180
Why?
Rectal Fistula
1
2021
27
0.170
Why?
Pancreatic Neoplasms
2
2021
853
0.170
Why?
Vascular Surgical Procedures
2
2021
310
0.170
Why?
Aftercare
1
2023
207
0.170
Why?
Liver Transplantation
2
2021
843
0.170
Why?
Prevalence
4
2025
2735
0.170
Why?
Follow-Up Studies
4
2021
5121
0.170
Why?
Gynecologic Surgical Procedures
1
2021
64
0.170
Why?
Esophagoscopy
2
2022
210
0.170
Why?
Artificial Intelligence
1
2024
291
0.170
Why?
Cystectomy
2
2017
41
0.170
Why?
Utilization Review
1
2020
40
0.170
Why?
Sugars
1
2020
39
0.160
Why?
Practice Guidelines as Topic
2
2025
1541
0.160
Why?
Digestive System Surgical Procedures
1
2021
104
0.160
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2020
36
0.160
Why?
Bone Density
1
2023
489
0.160
Why?
Bone Plates
1
2020
77
0.160
Why?
Carcinoma
1
2021
230
0.160
Why?
Urologic Surgical Procedures
1
2021
112
0.160
Why?
Tryptophan
1
2021
183
0.160
Why?
Quality Assurance, Health Care
1
2021
326
0.160
Why?
Diabetes Mellitus
2
2021
1052
0.160
Why?
Metagenomics
1
2021
177
0.150
Why?
Sensitivity and Specificity
1
2024
1941
0.150
Why?
Hospitals
2
2021
691
0.150
Why?
Deglutition Disorders
1
2021
148
0.150
Why?
Hospitals, Veterans
1
2020
255
0.150
Why?
Obesity, Morbid
1
2023
263
0.150
Why?
Child
6
2023
21833
0.150
Why?
Metabolomics
2
2022
686
0.150
Why?
Chronic Disease
2
2022
1788
0.150
Why?
Diverticulum
1
2018
12
0.150
Why?
Job Satisfaction
1
2021
215
0.150
Why?
Hematemesis
1
2018
3
0.140
Why?
Health Care Costs
1
2021
414
0.140
Why?
Infant
5
2020
9539
0.140
Why?
Symptom Assessment
2
2017
129
0.140
Why?
Carcinoma, Pancreatic Ductal
1
2021
265
0.140
Why?
Fracture Fixation, Internal
1
2020
192
0.140
Why?
Range of Motion, Articular
1
2020
407
0.140
Why?
Intestines
1
2021
354
0.140
Why?
Endoscopic Mucosal Resection
1
2017
25
0.140
Why?
Clostridium Infections
1
2018
72
0.130
Why?
Fatal Outcome
1
2018
309
0.130
Why?
Arthritis, Rheumatoid
2
2016
1156
0.130
Why?
Ambulatory Care
1
2021
571
0.130
Why?
Risk Assessment
3
2016
3438
0.130
Why?
Quality of Health Care
1
2021
649
0.130
Why?
Cystadenoma, Mucinous
1
2016
10
0.130
Why?
Continuity of Patient Care
1
2019
282
0.130
Why?
Budesonide
1
2016
56
0.130
Why?
Itraconazole
1
2016
8
0.120
Why?
Pharmacoepidemiology
1
2015
20
0.120
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2016
58
0.120
Why?
Endoscopy, Gastrointestinal
3
2023
229
0.120
Why?
Pancreatic Diseases
1
2016
66
0.120
Why?
Analgesics, Opioid
1
2024
1044
0.120
Why?
Guideline Adherence
1
2020
551
0.120
Why?
Cross-Sectional Studies
4
2025
5507
0.120
Why?
Cysts
1
2016
115
0.120
Why?
Epiphyses
1
2015
26
0.120
Why?
Hyperlipidemias
1
2016
124
0.120
Why?
Child, Preschool
5
2016
11102
0.120
Why?
Neoplasms, Second Primary
1
2016
112
0.120
Why?
Antirheumatic Agents
1
2018
291
0.120
Why?
Data Accuracy
1
2015
65
0.120
Why?
Arthritis, Juvenile
1
2015
54
0.110
Why?
Psoriasis
1
2016
106
0.110
Why?
Polypharmacy
1
2015
88
0.110
Why?
Adolescent
7
2019
21435
0.110
Why?
Elbow Joint
1
2015
75
0.110
Why?
Neoplasms
2
2023
2691
0.110
Why?
Hedgehog Proteins
1
2016
199
0.110
Why?
Young Adult
7
2019
13203
0.110
Why?
Interferon-gamma
1
2017
788
0.110
Why?
Prescription Drugs
1
2015
114
0.110
Why?
Burnout, Professional
1
2021
442
0.110
Why?
Dilatation
1
2014
67
0.110
Why?
Cholesterol
1
2016
400
0.110
Why?
Microbiota
1
2022
759
0.110
Why?
Immunologic Factors
1
2016
239
0.110
Why?
Anastomosis, Surgical
1
2014
155
0.100
Why?
Streptococcal Infections
1
2016
150
0.100
Why?
Virus Diseases
1
2016
212
0.100
Why?
Radiation Injuries
1
2014
147
0.100
Why?
Foreign Bodies
1
2014
105
0.100
Why?
Renal Insufficiency, Chronic
1
2019
619
0.100
Why?
Disease Progression
2
2021
2722
0.100
Why?
Early Detection of Cancer
3
2022
432
0.100
Why?
Registries
1
2021
2043
0.100
Why?
Reoperation
1
2015
579
0.100
Why?
Physical Therapy Modalities
1
2015
308
0.090
Why?
Primary Health Care
2
2022
1769
0.090
Why?
Epidemiology
1
2012
33
0.090
Why?
Diabetes Complications
1
2013
225
0.090
Why?
Patient Readmission
1
2017
701
0.090
Why?
Endoscopy
1
2014
313
0.090
Why?
Tissue and Organ Procurement
1
2015
319
0.090
Why?
Biomarkers
2
2020
4092
0.090
Why?
Research Support as Topic
1
2012
118
0.090
Why?
Age Distribution
1
2012
397
0.090
Why?
Time Factors
5
2021
6818
0.090
Why?
Predictive Value of Tests
1
2016
2017
0.080
Why?
Physicians
1
2019
924
0.080
Why?
Veterans
1
2021
1476
0.080
Why?
Prospective Studies
4
2024
7580
0.070
Why?
Medicare
3
2021
777
0.070
Why?
Drug Prescriptions
2
2024
257
0.070
Why?
Laparoscopy
1
2012
445
0.070
Why?
Emergency Service, Hospital
1
2019
2093
0.070
Why?
Neoplasm Staging
2
2022
1359
0.070
Why?
Academic Medical Centers
2
2021
506
0.060
Why?
Kaplan-Meier Estimate
2
2020
887
0.060
Why?
Pennsylvania
2
2017
131
0.060
Why?
Sex Factors
2
2025
2046
0.060
Why?
Breast Neoplasms
1
2016
2270
0.050
Why?
Survival Analysis
2
2017
1289
0.050
Why?
Multivariate Analysis
2
2017
1488
0.050
Why?
Regression Analysis
2
2017
1010
0.050
Why?
Piperidines
1
2024
206
0.050
Why?
Insurance Coverage
1
2024
233
0.050
Why?
Gastrectomy
1
2023
131
0.050
Why?
Replantation
1
2021
31
0.040
Why?
Cost Savings
1
2021
84
0.040
Why?
Granzymes
1
2021
49
0.040
Why?
Review Literature as Topic
1
2021
74
0.040
Why?
Documentation
1
2023
199
0.040
Why?
Training Support
1
2021
37
0.040
Why?
Fingers
1
2021
104
0.040
Why?
Salaries and Fringe Benefits
1
2021
56
0.040
Why?
Hand
1
2021
159
0.040
Why?
Morbidity
1
2021
319
0.040
Why?
Metabolic Networks and Pathways
1
2021
183
0.040
Why?
Perception
1
2022
366
0.040
Why?
Reproducibility of Results
2
2019
3287
0.040
Why?
SEER Program
1
2020
220
0.040
Why?
Dysbiosis
1
2021
182
0.040
Why?
Disease Susceptibility
1
2021
347
0.040
Why?
Physician's Role
1
2021
217
0.040
Why?
Medicine
1
2021
126
0.040
Why?
Age of Onset
1
2020
517
0.040
Why?
Gene Expression Regulation, Bacterial
1
2021
321
0.040
Why?
Delayed Diagnosis
1
2019
90
0.040
Why?
Career Choice
1
2021
227
0.040
Why?
Pharmacovigilance
1
2018
23
0.040
Why?
Mathematical Concepts
1
2018
32
0.040
Why?
Margins of Excision
1
2017
42
0.030
Why?
Decision Support Systems, Clinical
1
2021
238
0.030
Why?
Smoking
1
2025
1597
0.030
Why?
Prednisone
1
2018
216
0.030
Why?
Mercaptopurine
1
2016
15
0.030
Why?
Hip Fractures
1
2018
85
0.030
Why?
Etanercept
1
2016
59
0.030
Why?
Longitudinal Studies
1
2024
2836
0.030
Why?
Pilot Projects
1
2022
1742
0.030
Why?
Survival Rate
1
2021
1906
0.030
Why?
Clinical Competence
1
2024
1122
0.030
Why?
Computational Biology
1
2021
649
0.030
Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
2016
55
0.030
Why?
Decision Making
1
2023
937
0.030
Why?
Glomerular Filtration Rate
1
2019
745
0.030
Why?
Cause of Death
1
2018
424
0.030
Why?
Streptococcus pyogenes
1
2016
43
0.030
Why?
Intestinal Mucosa
1
2021
620
0.030
Why?
Weight Loss
1
2021
785
0.030
Why?
Methotrexate
1
2016
251
0.030
Why?
Statistics, Nonparametric
1
2015
424
0.030
Why?
Bias
1
2016
224
0.030
Why?
Neoplasm Invasiveness
1
2016
498
0.030
Why?
Gene Expression Profiling
1
2021
1752
0.030
Why?
Mental Recall
1
2015
205
0.030
Why?
Computer Simulation
1
2018
987
0.030
Why?
Medicaid
1
2018
439
0.030
Why?
Anticoagulants
1
2018
660
0.030
Why?
Waiting Lists
1
2015
259
0.030
Why?
T-Lymphocytes
1
2021
1979
0.020
Why?
Respiratory Tract Infections
1
2015
384
0.020
Why?
Cardiovascular Diseases
1
2018
2041
0.010
Why?
Scott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)